Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $589.65 million. The enterprise value is -$32.94 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RLAY has 172.41 million shares outstanding. The number of shares has increased by 26.88% in one year.
Current Share Class | 172.41M |
Shares Outstanding | 172.41M |
Shares Change (YoY) | +26.88% |
Shares Change (QoQ) | +1.20% |
Owned by Insiders (%) | 2.14% |
Owned by Institutions (%) | 67.87% |
Float | 110.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 66.35 |
Forward PS | 139.53 |
PB Ratio | 0.88 |
P/TBV Ratio | 0.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.92, with a Debt / Equity ratio of 0.05.
Current Ratio | 20.92 |
Quick Ratio | 20.19 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.24% and return on invested capital (ROIC) is -29.73%.
Return on Equity (ROE) | -46.24% |
Return on Assets (ROA) | -28.37% |
Return on Invested Capital (ROIC) | -29.73% |
Return on Capital Employed (ROCE) | -48.94% |
Revenue Per Employee | $32,011 |
Profits Per Employee | -$1.19M |
Employee Count | 261 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.47% in the last 52 weeks. The beta is 1.63, so RLAY's price volatility has been higher than the market average.
Beta (5Y) | 1.63 |
52-Week Price Change | -47.47% |
50-Day Moving Average | 3.47 |
200-Day Moving Average | 3.84 |
Relative Strength Index (RSI) | 47.48 |
Average Volume (20 Days) | 2,929,572 |
Short Selling Information
The latest short interest is 22.38 million, so 12.98% of the outstanding shares have been sold short.
Short Interest | 22.38M |
Short Previous Month | 21.52M |
Short % of Shares Out | 12.98% |
Short % of Float | 20.19% |
Short Ratio (days to cover) | 8.94 |
Income Statement
In the last 12 months, RLAY had revenue of $8.36 million and -$311.55 million in losses. Loss per share was -$1.92.
Revenue | 8.36M |
Gross Profit | -267.97M |
Operating Income | -340.77M |
Pretax Income | -322.83M |
Net Income | -311.55M |
EBITDA | -335.85M |
EBIT | -340.77M |
Loss Per Share | -$1.92 |
Full Income Statement Balance Sheet
The company has $656.78 million in cash and $34.18 million in debt, giving a net cash position of $622.59 million or $3.61 per share.
Cash & Cash Equivalents | 656.78M |
Total Debt | 34.18M |
Net Cash | 622.59M |
Net Cash Per Share | $3.61 |
Equity (Book Value) | 665.66M |
Book Value Per Share | 3.88 |
Working Capital | 647.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$261.42 million and capital expenditures -$637,000, giving a free cash flow of -$262.06 million.
Operating Cash Flow | -261.42M |
Capital Expenditures | -637,000 |
Free Cash Flow | -262.06M |
FCF Per Share | -$1.52 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -4,078.58% |
Pretax Margin | -3,728.89% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.88% |
Shareholder Yield | -26.88% |
Earnings Yield | -52.84% |
FCF Yield | -44.44% |
Dividend Details Analyst Forecast
The average price target for RLAY is $18.45, which is 439.47% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.45 |
Price Target Difference | 439.47% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 69.86% |
EPS Growth Forecast (5Y) | -17.79% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 3.33 and a Piotroski F-Score of 2.
Altman Z-Score | 3.33 |
Piotroski F-Score | 2 |